THOUSAND OAKS, Calif. (AP) — THOUSAND OAKS, Calif. (AP) — Atara Biotherapeutics Inc. (ATRA) on Friday reported a loss of $12.7 million in its fourth quarter.
The Thousand Oaks, California-based company said it had a loss of $1.19 per share.
The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of $3.82 per share.
The drug developer posted revenue of $32.8 million in the period.
For the year, the company reported that its loss narrowed to $85.4 million, or $11.41 per share. Revenue was reported as $128.9 million.
Atara Biotherapeutics shares have dropped 48% since the beginning of the year. In the final minutes of trading on Friday, shares hit $6.88, a drop of 60% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ATRA at https://www.zacks.com/ap/ATRA
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。